ABOUT US

Coriolis Pharma - outstanding biopharmaceutical research

Coriolis Pharma is a globally operating contract research and development organization (CRDO) and a leader in formulation research and development of biopharmaceutical drugs, including cell and gene therapy products and vaccines. We provide high-quality services for liquid and lyophilized drug products from early stage to commercialization and beyond. Manufacturing support and contract analytical services under R&D and GMP complete our service portfolio.

Our mission

Our motivation is to enable the development of innovative drugs by performing outstanding biopharmaceutical research to improve the quality of life for humankind.

Our vision

We enable innovative therapies by revolutionizing formulation development.

We revolutionize the development process of biopharmaceutical drugs by integrating innovative digital formulation approaches from drug development to commercial products. We thereby enable future therapies to be made available to humankind efficiently and on time.

Our strategy

For us innovation is progress achieved by collaboration. We generate innovation by combining technologies, knowledge and experience. Formulating for us means: to find the best solution right from the start combined with speed and flexibility.

Scientific Excellence

Research and development is more than just following a recipe: it is passion for the success of the project. Working with Coriolis means that we assemble a team of specific experts to meet the demand of your particular project. With many years of experience and a trouble-shooting mindset, our scientists love challenging projects. In a unique collaborative approach, our interdisciplinary team will create an environment that focuses on fulfilling your goals and expectations.

Pure dedication to your project

As a privately held company we are independent and accountable to nobody except you, our client. You and your project are at the center of our attention. We ensure that you deliver your results on-time and align our services to your specific molecule and development stage. Our scientific excellence paired with a troubleshooting and client-orientated mindset has made the difference for many clients already.

High-Quality Services

Our mission is to build quality into all our services as an enabler for efficient and sustainable drug development, which will help to improve quality of life of mankind. Through a comprehensive quality assurance system, we ensure the highest quality of our services on both R&D- and GMP-level. We offer R&D services from early-stage research phase, where we support your development efforts with flexible and tailor-made services, all the way to and beyond clinical trials, where we offer services in GMP compliance in dedicated facilities with full QA involvement.

Collaboration and Transparency

Working with Coriolis Pharma means collaboration, built on a unique level of transparency. We listen to you and we align our activities with your strategy and requirements. Dedicated project leader are responsible for each client to ensure a regular and effective communication.

Milestones

2008

Foundation of Coriolis Pharma

2009

Move to the IZB (Innovation and Start-Up Center for Biotechnology) in Martinsried

2012

GMP accreditation

2016/17

Biological Safety Level (BSL) 1 & 2 certification

2017

Move to new facilities in Martinsried

2021

Expansion into new facilities for ATMP development (up to BSL2)

2023 / Q1

15th anniversary of Coriolis Pharma

2023 / Q2

Coriolis secures investment from KKR

2024

Launch of U.S. entity & platform service offerings for mAbs

Facts & figures

15+

years of experience in biopharma development

200+

highly qualified employees

200+

different analytical methods in house

160+

peer reviewed scientific publications

750+

global clients from start-up to Big Pharma

2700+

projects performed successfully

Science matters

Your partner with scientific excellence

From discovery phase to and beyond market approval, Coriolis provides high-quality research, development, and analytical services. Our strategy is to generate innovation by combining technologies, knowledge, and experience. In collaborative partnership with our clients, we develop innovative drugs to improve the quality of life for humankind.